Chester County News and Community Website
MALVERN, PA — Biopharmaceutical company Ocugen, Inc. (NASDAQ: OCGN) has announced the commencement of its Phase 1/2 GARDian clinical trial for OCU410ST (AAV5-hRORA), a gene therapy candidate being developed to …
Ocugen Initiates Phase 1/2 GARDian Clinical Trial for Stargardt Disease Therapy Read More
The global biotech industry is on the cusp of a revolution with the advent of CRISPR and Cas gene technology. According to a recent report by Future Market Insights, Inc., …
The CRISPR and Cas Gene Market: A Future of Rapid Growth and Remarkable Innovations Read More
GMOs, or genetically modified organisms, are a hot topic in the news lately. But what are they, and why should you care? In this article, we will explain what GMOs …
GMOs: What They Are and What You Need to Know Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration announced it has made a low-risk determination for the marketing of products, including food, from two genome-edited beef cattle and their …
FDA Makes Low-Risk Determination for Marketing of Products from Genome-Edited Beef Cattle After Safety Review Read More